Advertisement SenoRx launches Contura MLB - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

SenoRx launches Contura MLB

SenoRx has launched Contura, its multi-lumen balloon catheter for delivering brachytherapy to the surgical margins following lumpectomy for breast cancer.

The company had previously reported that it intended to transition from user preference testing, which had expanded to 34 clinical sites by the end of 2007, to full commercial launch in January 2008.

Contura is said to be a new class of devices which is designed to reduce radiation treatment time to five days from six to eight weeks in patients eligible for the treatment. SenoRx believes that the Contura MLB can play an important role in the shift from traditional whole breast radiation therapy to localized partial breast radiation therapy.